Home LiteratureArticle Details
PMID: 6139620 Published · ppublish English Case Reports Journal Article

Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients.

Lancet (London, England) ·Vol. 2 ·No. 8362 ·1983-12-03 ·Pages 1274-6

Abouna GM, Al-Adnani MS, Kremer GD, Kumar SA, Daddah SK, Kusma G

Abstract

Two kidneys were removed from a cadaveric donor with 17-year history of type 1 diabetes. At the time of death the donor had proteinuria but normal serum creatinine, and on histological examination the kidneys showed features of established diabetic nephropathy including diffuse glomerulosclerosis and thickening of mesangial matrix and capillary basement membranes. After transplantation into non-diabetic recipients (cold ischaemia times 46 h and 52 h) the kidneys functioned well with standard immunosuppression. Renal biopsy specimens taken 7 months after transplantation showed almost complete resolution of the nephropathy and both patients remain free from proteinuria after a further 7 months. As well as indicating that longstanding type 1 diabetes need not always contraindicate kidney donation, these observations are relevant to the pathogenesis and management of diabetic nephropathy.

MeSH Terms
Adult Cadaver Diabetic Nephropathies/pathology Graft Survival Humans Kidney/pathology Kidney Failure, Chronic/surgery Kidney Function Tests Kidney Transplantation Male Middle Aged Tissue Donors
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Abouna G M
Al-Adnani M S
Kremer G D
Kumar S A
Daddah S K
Kusma G
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1983-12-03
Pages
1274-6
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com